Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens-Reference-Cited by-同舟云学术

Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens

Published:1979-10-19 Issue:4416 Volume:206 Page:347-349
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Kung Patrick C.¹,Goldstein Gideon¹,Reinherz Ellis L.²,Schlossman Stuart F.²

Affiliation:

1. Ortho Pharmaceutical Corporation, Raritan, New Jersey 08869

2. Division of Tumor Immunology, Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference20 articles.

1. BARNSTABLE, C.J., PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS, CELL 14: 9 (1978).

2. Cantor, H., Cold Spring Harbor Symposia on Quantitative Biology 41: 23 (1977).

3. CHESS, L, CONTEMPORARY TOPICS IN IMMUNOBIOLOGY 7: 363 (1977).

4. COSIMI, A.B., RANDOMIZED CLINICAL-TRIAL OF ANTITHYMOCYTE GLOBULIN IN CADAVER RENAL-ALLOGRAFT RECIPIENTS - IMPORTANCE OF T CELL MONITORING, SURGERY 80: 155 (1976).

5. EDELSON, R.L., ANTI-THYMOCYTE GLOBULIN IN THE MANAGEMENT OF CUTANEOUS T-CELL LYMPHOMA, CANCER TREATMENT REPORTS 63: 675 (1979).

Cited by 1334 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B;Antiviral Research;2024-09

2. Structural basis for bispecific antibody design: arrangement of domain linkage produces activity enhancement;2024-04-25

3. TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers;Nature;2024-03-27

4. Antibiotic Resistance: Do We Need Only Cutting-Edge Methods, or Can New Visions Such as One Health Be More Useful for Learning from Nature?;Antibiotics;2023-12-03

5. A multi-functional drug delivery nanosystem release of TLR-7 immunostimulant and OKT3 induced efficient cancer immunotherapy;Photodiagnosis and Photodynamic Therapy;2023-12